Images
Participants
Contact
The work of the Colorectal Cancer Laboratory published in Nature Genetics on the molecular classification of colon tumors has had a great impact on the media. The study shows that the malignancy of tumors lies in whether the cells surrounding the tumor are altered or not. The news highlights the promise that the results hold to develop a diagnostic test to predict the risk of metastasis in patients. Another striking result is the proposal to start clinical trials using inhibitors of an experimental drug that has proven to halt metastasis in mice.
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
